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Abstract
Pre-test counseling about multigene panel testing involves many uncertainties. Ideally, counselees are informed about uncer-
tainties in a way that enables them to make an informed decision about panel testing. It is presently unknown whether and 
how uncertainty is discussed during initial cancer genetic counseling. We therefore investigated whether and how counse-
lors discuss and address uncertainty, and the extent of shared decision-making (SDM), and explored associations between 
counselors’ communication and their characteristics in consultations on panel testing for cancer. For this purpose, consulta-
tions of counselors discussing a multigene panel with a simulated patient were videotaped. Simulated patients represented a 
counselee who had had multiple cancer types, according to a script. Before and afterwards, counselors completed a survey. 
Counselors’ uncertainty expressions, initiating and the framing of expressions, and their verbal responses to scripted uncer-
tainties of the simulated patient were coded by two researchers independently. Coding was done according to a pre-developed 
coding scheme using The Observer XT software for observational analysis. Additionally, the degree of SDM was assessed 
by two observers. Correlation and regression analyses were performed to assess associations of communicated uncertainties, 
responses and the extent of SDM, with counselors’ background characteristics. In total, twenty-nine counselors, including 
clinical geneticists, genetic counselors, physician assistants-in-training, residents and interns, participated of whom work-
ing experience varied between 0 and 25 years. Counselors expressed uncertainties mainly regarding scientific topics (94%) 
and on their own initiative (95%). Most expressions were framed directly (77%), e.g. We don’t know, and were emotionally 
neutral (59%; without a positive/negative value). Counselors mainly responded to uncertainties of the simulated patient by 
explicitly referring to the uncertainty (69%), without providing space for further disclosure (66%). More experienced coun-
selors provided less space to further disclose uncertainty (p < 0.02), and clinical geneticists scored lower on SDM compared 
with other types of counselors (p < 0.03). Our findings that counselors mainly communicate scientific uncertainties and use 
space-reducing responses imply that the way counselors address counselees’ personal uncertainties and concerns during 
initial cancer genetic counseling is suboptimal.
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Introduction
Multigene panels involve sequencing multiple genes simul-
taneously to identify genetic cancer predispositions [1]. An 
advantage of panel testing is the increased yield of genetic 
diagnosis, particularly in families fitting multiple cancer 
syndromes [2]. However, sequencing a large number of 
genes increases the level of uncertainty compared with more 
targeted tests [2, 3], as it increases the possibility to iden-
tify uncertain and unsolicited findings. This subsequently 
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generates uncertainties, such as what and how to communi-
cate to counselees during pre-test and post-test counseling 
[2].
Three categories of medical uncertainties have been 
identified in the current literature: (i) scientific, (ii) practi-
cal, and (iii) personal [4]. Scientific uncertainty comprises 
uncertainties regarding the evidence on diagnosis and impli-
cations for prevention, treatment and prognosis [5]. Practi-
cal uncertainty applies to processes of care, e.g. whether to 
communicate test results without clinical relevance. Lastly, 
personal uncertainty pertains to psychosocial and existential 
consequences for patients, e.g. whether uncertain informa-
tion should be disclosed to relatives [4].
During genetic counseling, large amounts of genetic 
information are generally provided by counselors to increase 
counselees’ knowledge and promote their understanding 
[6]. However, given the increased level of uncertainty con-
cerning panel testing, provision of uncertain information is 
expected to be more extensive in consultations about this 
type of test. One study showed that counselors struggle with 
the amount of uncertain information they need to provide in 
the context of panel testing, and that they vary in their com-
munication about uncertainty during pre-test counseling [7]. 
This implies that not all decisions of individual counselees 
regarding testing are based on the same information and that 
they may, therefore, strongly depend on the counselor. Ide-
ally, counselees are adequately provided with information, 
including information about uncertainties, irrespective of 
their individual counselor [6]. As counselees often engage 
in genetic counseling hoping to become more certain about 
their medical situation, e.g., by finding out whether or not 
they are a carrier, counselors need to make counselees 
aware of the possible uncertainties associated with panel 
testing to manage their expectations [8]. In particular, from 
counselees’ perspective there is no best option in deciding 
about multigene panel testing, since testing may involve both 
harms and benefits for them. Therefore, disclosing uncer-
tainties that may result from panel testing, is necessary to 
enable counselees to weigh the pros and cons of undergo-
ing such a test. Therefore, their autonomy is promoted as 
counselees are allowed to be involved in decision making 
and to decide together with the counselor according to their 
personal values, i.e. shared decision making (SDM) [9].
Similar to the content of uncertain information, the 
manner in which counselors communicate uncertainty may 
also vary. The effect of uncertainty communication may 
differ depending on its framing, e.g. adding a positive or 
negative value [10, 11]. One study showed that people’s 
attitude and behavior towards self-examination differ when 
adding a positive or negative value to risk information 
[12]. It is plausible that this also applies to the framing of 
uncertainty in consultations about panel testing; one may 
be more inclined to opt for panel testing when uncertainty 
is communicated in positive terms [13]. In the context of 
decision making, non-directive counseling is required to 
enable counselees to decide without being steered by their 
counselor [14]. However, some may argue that a positive 
or negative framing helps counselees contemplate their 
decision in certain situations. For example, when coun-
selees are strongly convinced that genetic testing has a 
negative outcome, counselors may use framing to help 
grow more realistic expectations in counselees.
Primarily counselors introduce uncertainties during 
genetic counseling, but counselees may express uncer-
tainty as well [15]. Counselees’ uncertainties may have 
existed before counseling, or be evoked by the uncertain-
ties introduced by the counselor (i.e. as a reaction to the 
provided information). If counselees express uncertainties, 
counselors need to respond to and deal with these during 
genetic counseling. Studies have examined how physicians 
respond to patient expressions like uncertainty [16], and 
how patients can be supported in dealing with these [17]. 
However, to our knowledge, no studies have investigated 
how counselors handle uncertainties expressed by couns-
elees during genetic counseling.
Hence, it is unknown whether and how counselors com-
municate about and respond to uncertainty resulting from 
multigene panel testing, and to what extent counselees are 
involved in deciding about panel testing. Therefore, this 
study aimed to gain insight into counselors’ discussion of 
uncertainty by (1) examining which uncertainties counse-
lors discuss and how, (2) examining how they respond to 
counselees’ expressions of uncertainty, and (3) describing 
the extent to which counselors engage in SDM in initial 
cancer genetic counseling about multigene panel test-
ing with a simulated patient (SP). Moreover, this study 
attempted to (4) explore associations between counse-
lors’ background characteristics and their communication 
of uncertainty, responses to uncertainty and the extent of 
SDM.
Materials and methods
Design and ethics
In this cross-sectional observational study, counselors dis-
cussed a multigene panel test with a SP. Creating so-called 
simulated consultations eliminates variation at patient 
level, enabling the use of one instead of multiple consulta-
tions per counselor. This method has previously been suc-
cessfully applied [18]. The Medical Ethics Review Board 
of the Academic Medical Center approved the study and 
waived the need for ethico-legal adjudication as it would 
have no serious impact on participating counselors.
‘We don’t know for sure’: discussion of uncertainty concerning multigene panel testing during…
1 3
Scenario
All simulated consultations were based on the same sce-
nario: a highly-educated male counselee who has had three 
types of cancer and visits for his first genetic counseling 
appointment concerning a pretest-counseling session about 
the option to perform a multigene panel test for cancer. One 
type of counselee was used in this study to enable standardi-
zation across consultations and thus to compare communica-
tion between counselors. A male counselee was chosen for 
practical reasons.
Simulated patients (SPs)
Two experienced male actors, comparable in age (± 60 
years old), were trained to act as SP1 and SP2 according to 
a script (Supplement A). The script contained background 
information, e.g. the reason for seeking cancer genetic coun-
seling, and instructions to provide two statements indicat-
ing uncertainty and to ask two specific questions during 
the consultation, e.g., ‘Oh, what if something unknown is 
determined... What am I supposed to do then..’. Further, SPs 
were instructed to follow the lead of the counselor, providing 
information or asking questions only when prompted.
SPs were trained twice in 2-h sessions to review the script 
and practice the case with a clinical geneticist in the pres-
ence of the research team. After the first session, the SPs 
acted in four pilot consultations with counselors not partici-
pating in this study, to test the script and SPs’ behavior, and 
to further adjust the script. During the second session, the 
final script was discussed and practiced.
Participants
In the Netherlands, genetic testing for cancer is performed 
at seven university medical centers and one oncology-spe-
cific tertiary referral center. Eligible for participation in the 
present study were all counselors (i.e., clinical geneticists, 
residents and interns, physician assistants (in training) and 
genetic counselors) affiliated with these centers and perform-
ing cancer genetic counseling. The study was advertised at 
all centers, and interested counselors received more details 
from the first author. To create a large and heterogeneous 
sample, clinical geneticists (both staff and residents), physi-
cian assistants and genetic counselors varying in years of 
working experience were recruited. To create an equal dis-
tribution across the centers, the aim was to recruit at least 
five counselors per institute, three of which were clinical 
geneticists.
Procedure
Data were collected between September 2017 and March 
2018. When counselors agreed to participate, a consultation 
with a SP was scheduled at the counselors’ own institute. 
Three weeks before this consultation, counselors gave writ-
ten informed consent and completed a questionnaire assess-
ing their background characteristics (T0). One week before 
the consultation, they received a brief instruction letter, a 
simulated medical file, and the SP’s pedigree. Counselors 
were instructed to conduct their consultation as they would 
do in routine clinical care and to take the time commonly 
needed for this type of consultation, which was on forehand 
specified to vary between 30 and 60 minutes in standard 
practice. Consultations were video-recorded and counse-
lors completed a questionnaire assessing their perception 
of realism and degree of SDM during this consultation (T1) 
immediately afterwards.
Measures
Background characteristics (at T0)
The following background characteristics of counselors were 
assessed:
(a) Socio-demographic, i.e. age and gender, and practice 
characteristics, i.e. professional training, years of coun-
seling experience, and experience in communication 
training.
(b) Confidence in discussing uncertainty, using a 5-item 
questionnaire which was developed for this study based 
on previous literature and existing questionnaire items 
from measures assessing related constructs [19]. All 
items were answered on a 7-point Likert response scale 
(1 = completely disagree and 7 = completely agree), 
with a maximum total score of 35. An example of one 
item is: I am very capable in discussing uncertainty 
about a panel test.
(c) Uncertainty tolerance, using the 5-item ‘Anxiety 
because of uncertainty’-scale of the Physicians’ Reac-
tion to Uncertainty (PRU) questionnaire with a 6-point 
Likert response scale, with a maximum total score of 
30 [20]. This questionnaire was translated to Dutch 
using forward–backward translation [21].
(d) Attitude towards SDM, using a 4-item questionnaire 
with a 7-point Likert response scale [22]. Maximum 
total score was 24 and scores < 12 were classified as 
a positive attitude and scores ≥ 12 as negative. Items 
were translated to Dutch using forward–backward 
translation [21].
(e) Perception of colleagues’ attitude towards SDM (i.e. 
perceived social norm) using a 2-item questionnaire 
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which was developed based on previous literature [23]. 
Answers were given on a 7-point Likert response scale 
(1 = completely disagree and 7 = completely agree; 
maximum total score of 14). For example, one item is 
Most counselors working in my center think it is impor-
tant to apply shared decision making in consultations 
about panel tests.
SDM (at T1)
We assessed counselors’ perception of the degree of SDM 
during the simulated consultation, using the Dutch version 
of the 9-item SDM-Q-Doc with a 6-point Likert response 
scale [24]. This questionnaire has been shown to have a good 
acceptance and reliability.
Realism (at T1)
Counselors’ perceived realism of the consultation was 
measured using a 3-item questionnaire with a 7-point Likert 
response scale (1 = completely disagree and 7 = completely 
agree). We used an adapted version of a questionnaire with 
a Cronbach’s alpha = 0.84, that has been used in previous 
studies of our research group (for example [25]). In addi-
tion, realism of SPs’ behavior was measured using a 2-item 
questionnaire (Cronbach’s alpha = 0.79) with a 7-point Lik-
ert response scale (1 = not at all and 7 = totally).
Content coding of consultations
Coding of counselors’ expressions of uncertainty All consul-
tations were coded by two coders (NM and PvM) indepen-
dently. To identify counselors’ expressions of uncertainty 
and their responses to counselees’ utterances of uncertainty, 
videos were coded according to a coding scheme using The 
Observer XT software for observational analysis of video 
recordings [26]. Details of the development and content of 
the coding scheme are provided in Supplement B. The final 
coding scheme included 42 detailed codes covering 13 top-
ics about which counselors could express uncertainty, cat-
egorized among four issues: scientific test-related, scientific 
disease-related, practical and personal uncertainties [4]. For 
each expression we also coded its initiation, i.e., counselor 
initiated or stimulated by the counselee, and framing, i.e., 
whether uncertainty was expressed directly, i.e. a decisive 
expression; e.g. We don’t know what it means, or indirectly, 
i.e. a hesitant expression; e.g. This pathogenic variant is 
probably not related to your cancer. Moreover, we coded 
whether neutral, positive or negative terms were used when 
expressing uncertainty, i.e. respectively ‘only’ disclosing 
uncertainty, adding a positive value (e.g. uncertainty does 
not necessarily imply something detrimental) or adding a 
negative value (e.g. an uncertain finding may turn out to be a 
pathogenic variant) to emphasize either one of the implica-
tions of uncertainty.
Coding of  counselors’ responses to  counselee expres-
sions of  uncertainty To code counselors’ responses to 
SPs’ utterances of uncertainty, the Verona Coding Defi-
nitions of Emotional Sequences (VR-CoDES) were used 
[16]. This system allows coding counselors’ responses to 
SPs’ scripted and spontaneous utterances of uncertainty in 
terms of their (a) explicitness, and (b) space. An explicit 
response includes a clear reference to counselees’ uncer-
tainty whereas a non-explicit response does not. Space 
refers to whether counselors reduced or provided space 
for the counselee to further disclosure uncertainty. An 
example of a response that reduces space is when a coun-
selor switches to another subject, e.g. SP: I’m worried 
about whether my children will develop cancer; Response 
of counselor: Does any of your children know that you’re 
here today?. Providing space is subdivided into content 
space, i.e., to explore the content of the uncertainty, for 
example; What is the reason you want to know whether 
you carry a pathogenic variant or not?, and affective 
space, i.e., to explore the affect associated with the uncer-
tainty, for example; Why do you think you’ll have difficulty 
in dealing with an uncertain variant?. The combination 
of these characteristics results in five response categories: 
(1) non-explicit, reducing space; (2) non-explicit, provid-
ing space; (3) explicit, reducing space; (4) explicit, pro-
viding content space; and (5) explicit, providing affective 
space (categories of VR-CoDES responses are presented 
in Fig. 1 in Supplement C).
Coding of SDM and realism The two coders independently 
assessed the degree of SDM, using the 9-item SDM-Q 
with a 6-point Likert response scale [27], adapted to be 
used as a coding instrument, and realism of SPs’ behavior, 
using a self-developed 3-item coding instrument with a 
maximum score of 6 per item.
Interrater reliability
After the two coders coded ten observations, interrater 
reliability of coded uncertainties, responses to uncertainty, 
SDM and realism was calculated. Since the interrater reli-
ability of coded uncertainties and responses was sub-opti-
mal (mean κ = 0.16; range 0.09–0.28), it was decided to 
double-code all observations independently. This would 
enable discussing and reaching consensus on any coding 
discrepancies, and thereby increase reliability. Reliability 
analyses on SDM data showed a moderate mean κ = 0.38; 
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range 0.03–0.92. Reliability of realism was judged to be 
substantial (Cohen’s Kappa κ = 0.60). After every five 
observations, coders met to compare their coding and if 
they disagreed, consensus was reached through discussion.
Statistical analysis
All statistical tests were performed using SPSS Statistics, 
version 21. Data distributions were checked for normality 
using visual inspections combined with parametric tests. 
Descriptive statistics were used to summarize counselors’ 
background characteristics, i.e. level of experience, profes-
sional training, uncertainty tolerance, confidence in com-
municating uncertainty, attitude towards SDM and perceived 
social norm about SDM. As a manipulation check, differ-
ences between consultations of the two SPs (i.e., differences 
in type of counselor, work experience, received communi-
cation training and mean duration of consultation) were 
assessed using independent t test or χ2-test, whichever was 
deemed more appropriate. Further, a consensus score was 
calculated of how realistic SPs’ behavior was rated by the 
two observers. Differences in realism scores as rated by 
counselors as well as observers were assessed using inde-
pendent t  test or χ2-test.
Counselors’ expressed uncertainties, its initiation and 
framing, and the responses to uncertainties were summa-
rized using descriptive statistics. To determine whether 
expressions of the four uncertainty issues (i.e. scientific 
test-related, scientific disease-related, practical and personal) 
differed in how they were framed, ratios of framing were 
calculated by dividing all uncertainty expressions related to 
one issue with one type of framing (e.g. all scientific test-
related uncertainties framed in direct positive terms) by 
the total number of uncertainty expressions related to that 
particular issue. Subsequently, a χ2-test was performed to 
test for differences in ratios. Further, a consensus score of 
the ratings of SDM by the two observers was calculated 
after which differences between observers’ and counselors’ 
ratings of SDM were assessed using independent t-test or 
χ2-test. This consensus score of SDM was used in further 
analyses on SDM.
The associations between the frequency of the four uncer-
tainty issues and counselors’ background characteristics 
were assessed using Pearson’s correlation or regression anal-
yses. This was also done to determine whether counselors’ 
background characteristics were correlated with each other. 
Further, we examined whether counselors’ responses  to 
uncertainties, e.g. providing space, and counselors’ SDM 
scores were correlated with counselors’ background charac-
teristics using Pearson’s correlation or regression analyses. 
Moreover, associations between the frequency of uncer-
tainty issues and counselors’ SDM scores, and between 
counselors’ responses to uncertainties, e.g. space providing, 
and counselors’ SDM scores were assessed using similar 
analyses.
Finally, a post-hoc power analysis was performed using 
G*Power version 3.1.9.2 [28]. Using an alpha of 0.05, we 
had a 50% power to determine medium effects (effect size 
of 0.3) with our sample size of 29. For all analyses, a sig-
nificant level of p < .0.05 was used.
Results
Sample characteristics
A total of 29 counselors from all Dutch genetic centers 
participated; range 1–6 per center. Characteristics of par-
ticipants are shown in Table 1. Mean duration of the con-
sultation was 34 min (SD = 7.1; range 20.4–47.5). Of all 
counselors, 16 had a consultation with SP1 and 13 saw 
SP2; there were no differences in counselors’ characteristics 
between those who saw SP1 or SP2.
Realism
Observers rated SPs’ behavior as equally realistic for both 
SPs (M = 12.4 vs. M = 12.7), which was also the case for 
counselors’ assessment of SPs. Counselors assessed the 
realism of SPs’ behavior significantly higher than observ-
ers (counselors; M = 14.9, observers; M = 12.8; t = 3.574; 
p < 0.001). Moreover, counselors assessed their consultation 
Table 1  Counselors’ characteristics (N = 29)
n (%) M ± SD (range)
Age (in years) 43.5 ± 1.9 (26–63)
Female 23 (79.3)
Professional training
 Clinical geneticist 16 (55.2)
 Genetic counselor 5 (17.2)
 Physician assistant-in-training 5 (17.2)
 Resident 1 (3.4)
 Intern 2 (6.9)
Work experience (in years) 11.8 ± 1.54 (0–25)
Received training in communication
 Never 3 (10.3)
 1–2 times 11 (37.9)
 3–5 times 10 (34.5)
 > 5 times 5 (17.2)
Confidence in discussing uncertainty 20.3 ± 3.7 (10–28)
Uncertainty tolerance 15.7 ± 3.6 (7–24)
Attitude towards SDM 7.1 ± 2.8 (4–15)
Perceived social norm about SDM 9.8 ± 1.6 (6–12)
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as moderately realistic (M = 7.8, range 5–11, with a possible 
maximum score of 12).
Communicated uncertainties
Topics of uncertainties
Table 2 shows characteristics and quotes of counselors’ 
uncertainty expressions (n = 1207), organized by topic. 
Almost all expressions were related to scientific uncer-
tainty (93.7%, including 42% test-related and 58% disease-
related expressions) while 0.3% referred to personal and 
6% to practical uncertainties. The following six topics of 
uncertainty were most frequently discussed, in 97% of the 
consultations: uncertainty regarding (1) heredity of cancer, 
(2) the consequences of an identified pathogenic variant, 
(3) the risk of developing cancer, (4) possible test results, 
(5) the meaning and implications of test results, and (6) 
possibilities of genetic techniques. Four uncertainty topics 
were rarely addressed by counselors: the counselees’ future 
in general, the cause of a pathogenic variant, whether and 
when to perform genetic testing, and what to communicate 
to counselees.
Initiative and framing of uncertainty
Most expressions of uncertainty (95%) were initiated by the 
counselor, and framed directly (77%), e.g., In that case it 
is unknown what this means vs. 23% indirectly, e.g., It is 
probably a harmless variant. More than half of the directly-
framed uncertainty expressions was furthermore framed in 
emotionally neutral terms (59%, e.g., There’s a possibility 
to find something of which it is unknown whether it caused 
your cancer) while in 26% a negative value was added, e.g., 
Which might be difficult to deal with, and in 16% of the utter-
ances a positive value accompanied the uncertainty expres-
sion, e.g., It might enable us to start screening.
Ratios of framing differed between scientific test-related, 
scientific disease-related, practical and personal uncertain-
ties (p < 0.001). Scientific test-related uncertainties were 
more frequently framed in direct, positive terms (15%) com-
pared to the other topics (≤ 6%). Further, scientific disease-
related uncertainties were frequently framed in indirect, 
neutral terms (11%).
Counselors’ responses to uncertainty
Most of counselors’ responses to SPs’ uncertainty expres-
sions (n = 350) were explicit (69%; i.e. referring to SPs’ 
uncertainty expression). Moreover, 66% of these responses Ta
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reduced space for the counselee to further disclose his 
uncertainty. The most frequently used type of explicit space-
reducing response was categorized as information-advice, 
i.e. situations where counselors would answer a question or 
offering reassurance by providing information (Table 3). In 
only 5% of their responses, counselors explicitly provided 
space for or explored counselees’ affective experiences with 
uncertainty, e.g., by addressing counselees’ ability to deal 
with possible uncertainty resulting from genetic testing.
Shared decision making (SDM)
Observers’ rating of counselors’ degree of SDM resulted in 
a mean score of 24.3 (SD = 5.6; range 6–34), which was sig-
nificantly lower than counselors’ own ratings of the degree 
of SDM in the consultation (i.e. M = 31.4; range 22–39, 
respectively, p <  0.001).
Associations with counselors’ characteristics
No associations between the frequency of communicated 
uncertainties and counselors’ level of experience, profes-
sional training, tolerance of uncertainty, confidence in com-
municating uncertainty, attitude towards SDM or perceived 
social norm about SDM was demonstrated (all r < 0.10, 
all p-values > 23). There was a trend for more experienced 
counselors to feel more confident about discussing uncer-
tainty (r = 0.34; p = 0.08), but no association with their tol-
erance to uncertainty was found here (r = 0.22; p = 0.26), 
despite a trend for more confidence in discussing uncertainty 
being related to being more tolerant to uncertainty (r = 0.35; 
p =  0.06).
More experienced counselors were significantly less 
likely to respond to SPs’ uncertainty by providing space for 
further disclosure of the SPs’ uncertainty, e.g. by asking a 
follow-up question about the expressed uncertainty of the SP 
(r = 0.43, p = 0.02). There was a trend for counselors with a 
more positive attitude towards SDM to use fewer explicit 
responses to SPs’ expressions of uncertainty (r = − 0.33, 
p = 0.08).
Clinical geneticists scored significantly lower on degree 
of SDM than residents or genetic counselors (p < 0.03; 
M = 22.3 vs. M = 26.8). Also, a more negative attitude 
towards SDM was significantly associated with a lower 
degree of SDM during the consultation: r = − 0.38; p = 0.04. 
The degree of SDM was not found to be associated with 
years of experience (r = − 0.20; p = 0.29), training in com-
munication skills (χ2 = 45.7; p = 0.32), or perceived social 
norm (r = 0.07; p = 0.72).
Communicated uncertainties and responses 
in relation to SDM
A higher degree of observers’ rating of SDM was related to 
significantly more frequent discussion of practical and per-
sonal uncertainties (r = 0.58 (p < 0.01); r = 0.41 (p < 0.03), 
respectively), but not shown here to be significantly related 
to discussion of scientific disease-related or test-related 
uncertainties (r = − 0.26 (p = 0.17); r = − 0.08 (p = 0.69), 
respectively). No associations were found between degree of 
SDM and counselors’ responses towards SPs expressions of 
uncertainty (all r values < 0.25; all p-values > 0.17).
Discussion
In this observational study using simulated patients (SPs), 
we aimed to gain insight into whether and how counselors 
discuss and address uncertainty and engage in shared deci-
sion making (SDM) when discussing a multigene panel test. 
Moreover, we attempted to investigate whether counselors’ 
Table 3  Number of responses, consultations, frequency and duration 
of responses (n = 350) during simulated consultations (n = 29)
a Total number of responses for each category among the 29 consulta-
tions
b Mean frequency and standard deviation of responses per consulta-
tion
Categories of VR-CoDES responses 
and their codes (number of consulta-
tions)
Number of 
responses (n 
(%))a
Frequency 
(mean ± 
SD)b
Non-explicit, reducing space (n = 24) 52 (14.9) 2.2 ± 1.1
 Ignoring 20 (38.5) 1.1 ± 0.3
 Shutting down 2 (3.8) 1.0 ± 0.0
 Information-advise 30 (57.7) 1.9 ± 1.1
Non-explicit, providing space (n = 27) 58 (16.6) 2.1 ± 1.5
 Silence 2 (3.4) 1.0 ± 0.0
 Back-channel 16 (27.6) 2.0 ± 1.2
 Acknowledgement 15 (25.9) 1.3 ± 0.5
 Active Invitation 5 (8.6) 1.3 ± 0.5
 Implicit empathy 20 (34.5) 1.5 ± 0.9
Explicit, reducing space (n = 29) 178 (50.9) 6.1 ± 2.1
 Switching 11 (6.2) 1.0 ± 0.0
 Post-ponement 7 (3.9) 1.2 ± 0.4
 Information-advise 144 (80.9) 5.0 ± 1.9
 Active blocking 16 (9.0) 1.2 ± 0.4
Explicit, providing space content 
(n = 21)
43 (12.3) 2.0 ± 1.1
 Content acknowledgment 27 (62.8) 1.5 ± 0.7
 Content exploration 16 (37.2) 1.5 ± 0.7
Explicit, providing space affective 
(n = 11)
19 (5.4) 1.7 ± 0.9
 Affective acknowledgement 11 (57.9) 1.4 ± 0.5
 Affective exploration 3 (15.8) 1.5 ± 0.7
 Empathic response 5 (26.3) 1.0 ± 0.0
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characteristics were associated with their communication, 
responses and extent of SDM.
Nearly all uncertainties communicated by counselors per-
tained to scientific topics, were initiated by the counselor 
and framed directly, meaning that the counselor explicitly 
voiced uncertainty, e.g. by saying I do not know as opposed 
to maybe. In addition, most expressions of uncertainty 
were framed emotionally neutral, i.e. without a positive or 
negative valence. Counselors generally acknowledged SPs’ 
uncertainty expressions by using explicit responses; meaning 
that SPs’ expressions were not ignored but explicitly referred 
to. However, counselors’ responses mainly precluded the 
opportunity to first explore SPs’ uncertainties before provid-
ing information or advice. Interestingly, more experienced 
counselors used more space-reducing responses. Further-
more, we found a moderate level of SDM (slightly above 
average [27]), with clinical geneticists scoring significantly 
lower than other types of counselors. Consultations with 
relatively high SDM scores contained significantly more 
discussions of SPs’ practical and personal uncertainties. 
Our small sample size prevented us from drawing firm con-
clusions on other, non-significant associations with coun-
selors’ characteristics. Not surprisingly, mainly scientific 
uncertainties (e.g. whether knowledge of genetic variants 
will increase in the future) were communicated at counse-
lors’ initiative, since genetic counseling is primarily aimed 
at informing counselees about and promoting their under-
standing of genetic information [4, 6]. For this, counselors 
generally provide large amounts of information, including 
uncertain information [29]. More importantly, this study 
showed that counselors differ in the uncertain information 
they address: some scientific uncertainties, but particularly 
many practical and personal uncertainties, were not identi-
fied in all consultations (Table 2). Possibly, counselors try 
to enhance counselees’ understanding and recall by avoiding 
information overload and selecting the uncertain informa-
tion they judge to be important to provide. Since the recall 
of medical information is generally low [30], this might be 
a sensible strategy. However, the variation in the commu-
nicated uncertainties during genetic counseling may result 
in practice variation causing counselees to differ in their 
genetic knowledge after counseling. Subsequently, couns-
elees’ decisions regarding testing may depend more on the 
counselor than on the information required to be provided, 
e.g. as proposed in the informed consent model of Brad-
bury et al. [31]. Our findings indicate that consensus among 
counselors and genetic centers is needed regarding the topics 
and extent to which uncertainties should be discussed with 
counselees during pre-test counseling. Before we can estab-
lish such consensus, we first need to know how different 
approaches in communicating uncertainty affect counselees 
and the degree to which SDM is applied.
We also found that counselors mainly responded to SPs’ 
expressions of uncertainty with space-reducing responses, 
of which the most frequently used was information-advice, 
i.e. providing information, or offering reassurance by pro-
viding information. Counselors may use this response after 
an uncertainty expression of the counselee to reduce his/
her uncertainty or to answer their question. However, pro-
viding information does not necessarily reduce uncertainty, 
as additional information may increase the complexity in 
understanding [5]. In addition, the content of responses 
may not only involve unambiguous information. A reas-
suring response may for example include information on 
the magnitude of a probability: I understand your concern; 
however, the chance of developing cancer again is really 
small. Hence, responding with additional information may 
generate ‘new’ uncertainties in counselees.
Further, results indicated that more experienced coun-
selors used more responses that reduced space for further 
disclosure of uncertainty. More experienced counselors 
might have developed a clear strategy for the structure and 
content of the consultation, leaving less space and attention 
for other topics of uncertainty contributed by the counselee 
[32]. Possibly, counselors are worried that using space-
providing responses may result in longer consultations. It 
would therefore be interesting for future research to examine 
whether providing more space to counselees to express their 
uncertainties has an impact on consultation duration and 
whether or not it is more efficient for counselors to address 
counselees’ uncertainties and to tailor the information to 
the individual counselee. In addition, future research should 
examine to what extent counselees experience (in)sufficient 
space to express their uncertainties. To gather such informa-
tion, research involving real counselees is needed.
Regarding decision making, SDM scores are promising 
for the level of involvement of counselees in decision mak-
ing about multigene panel testing during genetic counseling. 
On average, counselors’ degree of SDM was assessed as 
moderately, which can be considered as relatively high com-
pared to other healthcare settings [33]. This is consistent 
with the findings of a recent study showing that counselors 
indicated to attach great value to counselees’ preferences 
regarding performing a panel test, as panels imply increased 
uncertainty [7]. Additionally, the current study showed that 
uncertainties were mainly framed directly and in neutral 
terms. This supports the principle of non-directive coun-
seling, i.e. not necessarily raising hope or emphasizing the 
difficulty in dealing with uncertainty by using negative or 
positive terms to emphasize either one of the sides of uncer-
tainty. A neutral framing of uncertainty allows counselees 
to form their own opinion about these uncertainties and to 
determine the weight of these uncertainties in decision-mak-
ing [34]. Counselors might be aware that, regarding panel 
testing, there is no best option for an individual patient as it 
 N. M. Medendorp et al.
1 3
also involves potential drawbacks, which encourages them to 
avoid steering and involving counselees more extensively in 
decision-making [35]. However, the high number of space-
reducing responses used to respond to SPs’ uncertainties 
raises questions about counselees’ involvement. Although 
no significant associations were found between the coun-
selors’ responses to SPs expressions of uncertainty and 
their level of SDM, providing less space for counselees’ 
uncertainties may not be beneficial for their involvement in 
decision-making, as they are not able to share their concerns 
and considerations [36]. One strategy to involve counselees 
more extensively might be to pay more attention to explor-
ing their uncertainties, which may also help counselors to 
determine what information to provide [36]. Subsequently, 
counselors may reduce counselees’ uncertainty by tailoring 
the information to their needs and uncertainties according 
to the tiered-binned model of informed consent [31]. This 
model aims to achieve informed consent by differentiating 
between indispensable information and information tailored 
to individual informational needs to support informed deci-
sion making and minimize information overload. Moreo-
ver, tailoring information will increase counselees’ ability 
to overthink the pros and cons of testing. Although over-
thinking has the potential to be detrimental for counselees, it 
also enables counselees to be involved in the decision about 
panel testing which follows ethical standards [36]. It might 
therefore be relevant to provide counselors with guidelines 
on how to optimally discuss uncertainties with counselees 
and involve them in decision making during consultations 
about panel testing. Communication skills training may be 
an appropriate method to equip them with the required skills 
for adequate counseling [37].
Strengths and limitations
This study has some strengths and limitations that should be 
addressed. A first strength is that counselors of all genetic 
centers in the Netherlands and varying in professional train-
ing were included, providing a reasonable representation of 
Dutch clinical practice. Second, standardization of patient 
characteristics and elimination of confounding by patient 
characteristics was allowed by using actors instead of real 
counselees. This enabled us to gain insight into variation 
in communication behavior, as all counselors consulted 
with a male, 60-year old highly educated counselee. One 
limitation is that the number of participating counselors 
varied per center, possibly causing bias in the communica-
tion in clinical practice as genetic centers may differ in their 
approach. Second, our small sample size reduced the power 
to demonstrate small or even medium effects. We therefore 
cannot draw any strong conclusions on the non-significant 
associations that we found between communication and 
counselor characteristics. Third, using a simulated setting 
might have influenced counselors’ communication. Coun-
selors perceived SPs’ behavior as realistic, however, the 
consultation as a whole was assessed as only moderately 
realistic. This may be due to our instructions to discuss a 
multigene panel test during an initial counseling session. 
As there is no standard practice in the Netherlands, centers 
differ in their approach to requesting and offering multigene 
panel testing in clinical practice. Therefore, in this study 
counselors may have been forced to conduct this consulta-
tion different than usual, which may have influenced their 
communication. Also, characteristics of the SP such as gen-
der and educational level, may have determined counselors’ 
communication. Our SPs were older highly-educated men. 
Counselors may have perceived the SP as relatively well-
literate, causing them to be relatively open about scientific 
uncertainty. Moreover, previous literature indicates that phy-
sicians may interact differently with male vs. female patients, 
limiting generalizability of our study findings [38]. It would 
be interesting for future research to assess whether coun-
selors’ communication about uncertainty varies based on 
the counselee’s gender. Fourth, we used some study-specific 
questionnaires. For future use, our newly developed meas-
ures need to be validated. Finally, all videos were double-
coded independently and, as the interrater reliability of 
coded uncertainties and responses was suboptimal, coded 
fragments were discussed in the research team to reach con-
sensus. Identifying and coding expressions of uncertainty 
is, therefore, not straightforward. It would be relevant for 
future research to establish consensus on how uncertainty 
can be reliably coded.
Conclusion and recommendations
This study provides insight into counselors’ communication 
of and responses to uncertainties in the context of deciding 
about multigene panel testing for cancer. Our findings con-
tribute to the literature regarding counseling about multigene 
panel testing, which increasingly occurs in clinical practice. 
Our results show that cancer genetic counseling currently 
focuses on providing information that involves uncertain-
ties about scientific topics. We suggest to also focus on the 
personal, informational needs of counselees as this might be 
beneficial in order to address their uncertainties and involve 
them more extensively in decision-making. Future research 
should investigate counselees’ perspective on whether/how 
uncertainties should be addressed. Building on insights 
gained from this study (and from other studies address-
ing the counselees’ perspective) a training for counselors 
in communicating about panel testing will be developed, 
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aiming to improve their knowledge of and skills in coun-
seling about multigene panel testing.
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